Furthermore, previous studies have demonstrated a strong correlation between the expression of PD-L1 and poor prognosis in different solid tumors, including glioblastoma, pancreas, ovarian, breast, renal cell carcinomas, head and neck squamous cell carcinomas, esophageal, and non-small cell lung cancers [27, 29, 37-41]. Here, CD274 is linked to glioblastoma.